Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,860.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 829,710
  • Market Cap: £1,228.21m
  • RiskGrade: 128

Friday broker round-up

By Caoimhe Toman

Date: Friday 15 Nov 2019

LONDON (ShareCast) - (Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.

Tyman: Liberum reiterates buy with a target price of 300p.

Experian: Deutsche Bank upgrades to hold with a target price of 2,200p.

Burberry: Deutsche Bank reiterates hold with a target price of 2,010p.

AstraZeneca: Liberum Capital reiterates buy with a target price of 8,250p.

GlaxoSmithKline: Jefferies reiterates buy with a target price of 1,850p.

Workspace: Berenberg downgrades to sell with a target price of 950p.

Berkeley Group: Goldman Sachs downgrades to sell with a target price of 3,860p.

Burberry: Credit Suisse reiterates outperform with a target price of 2,700p.

Genus: Jefferies initiates hold with a target price of 3,272p.

Wetherspoon: Barclays reiterates overweight with a target price of 1,690p.

RHI Magnesita: Barclays reiterates overweight with a target price of 4,400p.

Ted Baker: RBC Capital Markets reiterates sector performer with a target price of 440p

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,860.00p
Change Today -8.00p
% Change -0.43 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 829,710
Shares Issued 66.03m
Market Cap £1,228.21m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 14-May-2024

Time Volume / Share Price
16:35 26,212 @ 1,860.00p
16:35 52 @ 1,860.00p
16:35 364 @ 1,860.00p
16:35 364 @ 1,860.00p
16:35 62 @ 1,860.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page